Rivian Beats Q2 Expectations, Raises 2026 Outlook as R2 Deliveries Begin
Rivian reported 12,194 vehicle deliveries in Q2 2026, exceeding expectations. The company raised its 2026 forecast and started R2 customer deliveries.
NOTRELOAD AI
United Therapeutics Acquires Thymmune Therapeutics for $300M to Advance Thymus-Based Regenerative Therapies
The deal accelerates United Therapeutics’ pipeline in immune restoration and transplant tolerance.
Arcturus Therapeutics Shares Surge on Thermo Fisher Collaboration for Cystic Fibrosis mRNA Therapy
Arcturus teams up with Thermo Fisher to develop a new cystic fibrosis mRNA drug, boosting shares on hopes for faster progress.
Mizuho Raises Robinhood Price Target to $130, Sees It Becoming the First Global Brokerage “Hyperscaler”
Analyst sees Robinhood becoming the first global brokerage hyperscaler with Europe and Asia expansion.
DA Davidson Upgrades Palantir to Buy, Sees 34% Upside as AI Orchestration Demand Accelerates
DA Davidson turns bullish on Palantir ahead of the U.S. 250th anniversary, highlighting its AI platform leadership and model-agnostic infrastructure.
AVAV Boosted by $500M Counter-UAS Contract Amid Wedbush Outperform Rating
Strong “Outperform” ratings from Wedbush on AeroVironment and Kratos Defense. Defense drone and multi-domain tech poised for growth.